NFKB1 and nasopharyngeal carcinoma: As far as we know, this is the first time to investigate the impact of SNPs in the cell cycle pathway and NF-κB signaling pathway genes on the efficacy and toxicity of radiotherapy in NPC patients treated with radiotherapy (or chemoradiotherapy).